Patent ID: 11963947
Assignee: HUA MEDICINE (SHANGHAI) LTD.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 0:
1. A fixed dose combination formulation, comprising:
(a) a glucokinase activator, which is a compound represented by the following formulae, or a pharmaceutically acceptable salt, an isotope labeled analogue, a crystalline form, a hydrate, a solvate, a diastereomeric or enantiomeric form thereof,, (b) a DPP-IV inhibitor, wherein the DDP-IV inhibitor is sitagliptin or sitagliptin phosphate monohydrate; and
(c) one or more excipients, wherein the weight ratio of the glucokinase activator to the DPP-IV inhibitor is about 4:1 to about 5:1.